While systemic chemerin in patients with T2DM was significantly elevated compared to normal-weight controls in the Caucasian population (Weigert et al. 2010), it was not changed or even reduced in Asian T2DM patients without other metabolic complications (Yang et al. 2010, Takahashi et al. 2013). This evidence concerns the gene RARRES2 and type 2 diabetes mellitus.